HIGHLIGHTS
- who: R. Korenblik from the (UNIVERSITY) have published the research: Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy, in the Journal: (JOURNAL) of February/17,/2020
- what: The 1 trial aims to assess implementation safety and feasibility of combined and_(PVE/HVE) to accelerate future remnant (FLR) in patients with borderline resectable The aim of DRAGON 1 is to assess the safety of the PVE/HVE procedure together with obtaining insight in the accrual ability of each individual . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.